Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CURX

Curanex Pharmaceuticals Inc

Feb 13 • 04:00PM ET

0.2864

+0.0092 3.32 %

Healthcare • Biotechnology • USA • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.05	Insider Own	69.26%	Shs Outstand	28.34M	Perf Week	3.77%
Market Cap	8.12M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	8.71M	Perf Month	-20.02%
Enterprise Value	2.35M	PEG	-	EPS next Q	-	Inst Own	1.30%	Short Float	0.80%	Perf Quarter	-50.27%
Income	-1.29M	P/S	-	EPS this Y	-	Inst Trans	85.77%	Short Ratio	0.32	Perf Half Y	-
Sales	0.00M	P/B	0.57	EPS next Y	-	ROA	-17.05%	Short Interest	0.07M	Perf YTD	-13.37%
Book/sh	0.50	P/C	1.39	EPS next 5Y	-	ROE	-17.27%	52W High	9.18 -96.88%	Perf Year	-
Cash/sh	0.21	P/FCF	-	EPS past 3/5Y	- -	ROIC	-9.02%	52W Low	0.26 9.31%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.96% 9.80%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-437.65%	Oper. Margin	-	ATR (14)	0.03	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	77.53	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	37.56	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	77.53	EPS Q/Q	-836.11%	SMA20	-10.96%	Beta	-	Target Price	-
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-21.76%	Rel Volume	0.22	Prev Close	0.28
Employees	-	LT Debt/Eq	0.00	Earnings	-	SMA200	-78.49%	Avg Volume	218.80K	Price	0.29
IPO	Aug 26, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	48,943	Change	3.32%

Oct-22-25 07:00AM	Curanex Pharmaceuticals Inc. Engages Strategic Investor Relations to Enhance Investor Communications and Engagement (GlobeNewswire) +14.39%
Sep-12-25 02:46PM	Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters (GlobeNewswire)
Aug-27-25 05:00PM	Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering (GlobeNewswire) +15.92% +11.37%
Aug-26-25 07:30AM	Curanex Pharmaceuticals Inc. Announces Pricing of its Initial Public Offering (GlobeNewswire)

Curanex Pharmaceuticals, Inc. engages in the pharmaceutical business. It focuses on developing and commercializing botanical treatments for inflammatory diseases. The company was founded by Ying Jing and Chang Liu in 1996 and is headquartered in Jericho, NY.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CURX

Curanex Pharmaceuticals Inc

Upgrade your FINVIZ experience